On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

On this week’s Tech Nation, Moira speaks with Dr. Paul Leonardi from UC Santa Barbara about “Digital Exhaustion: Simple Rules for Reclaiming Your Life”. Then, a promising new approach to flu shots! Dr. Jeff Stein from Cidara Therapeutics describes their efforts, now fast-tracked by the FDA.

On this week’s Tech Nation, Moira speaks with Dr. Paul Leonardi from UC Santa Barbara about “Digital Exhaustion: Simple Rules for Reclaiming Your Life”. Then, a promising new approach to flu shots! Dr. Jeff Stein from Cidara Therapeutics describes their efforts, now fast-tracked by the FDA.

On this week’s Tech Nation, Moira speaks with Dr. Frank Putnam, Psychiatrist and author of “Old Before Their Time” about his 35-year scientific investigation into the long-term biological effects of child abuse - and how trauma early in childhood can actually change the way a person ages. Then, Dr. Will Decker & Jay Hartenbach discuss how a discovery made over two decades ago set the stage for Diakonos Oncology’s new approach to treating glioblastoma… with a drug now entering phase two clinical trials.

On this week’s Tech Nation, Moira speaks with former New York Times journalist Katie Hafner about the Lost Women of Science initiative and what they’re doing to find and share the stories of women in science whose work has gone unrecognised. Then, CEO Lisa Deschamps tells us how Aviado Bio is working to correct the gene driving many cases of frontotemporal dementia.

On this week’s Tech Nation, Moira speaks with Physician and Entrepreneur, Dr. Jeremy Levin, about the big picture of biotech - and how it affects us all. They discuss the challenges facing the industry today: from global pandemics to funding cuts, to politics influencing innovation - and what it means for the future of health in the US. Dr. Levin’s book is, “Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust”

On this week’s Tech Nation, UC Berkeley Business and Entrepreneurship Professor, Dr. Toby Stuart, has studied the "Anointed" – those people who seem to get all the "good stuff". You'll learn how to recognise it. His book is “Anointed … The Extraordinary Effects of Social Status in a Winner-Take-Most World”.

On this week’s Tech Nation, what sets a great company apart from the rest? Moira speaks with Eric Ries about his book, “Incorruptible: Why Good Companies Go Bad and How Great Companies Stay Great”. Then, Dr. Steve Harr tells us how Sana Biotechnology is working to engineer insulin-producing cells for Type I diabetics, without the need for immunosuppressant drugs.

On this week’s Tech Nation, Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of the first real breakthrough in snake antivenom in 125 years, all thanks to a man who's been bitten by over 200 venomous snakes. Then, Robert Blum, CEO of CytoKinetics, shares the latest in heart failure treatment and what it could mean for extending quality of life.

On this week’s Tech Nation, Dan Wang from Stanford University’s Hoover History Lab sees the similarities between China and the US in his book: “Breakneck: China’s Quest to Engineer the Future”, and finally - the development of a simple wearable to gauge your true hydration levels. Brisbane, Australia's Dr. Mark Kendall from WearOptimo tells us how it works